The BioSpace 40 Under 40 winner opens up about his very personal career transformation from wealth management to biotech—and ...
KYV-101 resulted in a profound reduction in disease-associated autoantibodies and impact on disease activity in patients with difficult-to-treat rheumatoid arthritis (RA) KYV-101 continues to demonstr ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback